A 410099.1 amide-PEG3-amine-Boc

Background Introduction

A 410099.1 amide-PEG3-amine-Boc is a specialized E3 ligase ligand-linker conjugate designed for use in targeted protein degradation technologies, particularly PROTAC (Proteolysis Targeting Chimera) development. As interest in targeted protein degradation grows, such linkers play a crucial role in connecting E3 ligase recruiting ligands with ligands for proteins of interest, forming functional PROTACs. The incorporation of PEG3 (triethylene glycol) enhances solubility and flexibility, while the Boc-protected amine provides convenient functionalization for synthetic manipulation.

Mechanism

A 410099.1 amide-PEG3-amine-Boc operates as a modular component in the synthesis of PROTAC molecules. The molecule features an E3 ligase ligand, a PEG3 linker providing optimal spacing and solubility, and a terminal amine protected by a Boc group. Upon removal of the Boc protecting group, the amine can be selectively conjugated to small molecule inhibitors, peptides, or other proteins of interest. The resulting bifunctional molecule recruits the E3 ubiquitin ligase complex to the target protein, promoting ubiquitination and subsequent proteasomal degradation. This targeted degradation approach enables precise control over protein homeostasis, which is invaluable in functional studies and drug discovery.

Applications

A 410099.1 amide-PEG3-amine-Boc is broadly applied in the synthesis of PROTACs for targeted protein degradation research. It facilitates the rapid development of novel PROTAC degraders against disease-relevant targets, particularly in oncology, neurodegenerative diseases, and immunology. The Boc-protected amine allows for versatile synthetic strategies, making this conjugate suitable for high-throughput screening, mechanism-of-action studies, and the development of next-generation therapeutics. By enabling the design of highly selective PROTACs, it accelerates the discovery and validation of new drug targets and expands the potential treatment landscape for previously undruggable proteins.

• Amide-PEG3-amine-Boc provides excellent aqueous solubility for improved PROTAC bioavailability.
• Versatile amine-Boc group enables efficient conjugation with diverse E3 ligase ligands and target proteins.

The E3 Ligase Ligand-Linker Conjugate, A 410099.1, plays a pivotal role in the development of PROTACs by facilitating the recruitment of E3 ligase to target proteins for degradation. This conjugate is designed to enhance specificity and efficiency, offering a versatile platform for targeted protein degradation. The following provides a detailed description of this molecule.

Linker: The linker in this molecule is an amide-PEG3 chain, providing moderate length and flexibility. The PEG3 component offers hydrophilicity, enhancing solubility, while the amide bond ensures stability. This linker is non-cleavable, which supports sustained interaction between the target protein and E3 ligase.

Ligand: The ligand component is characterized by a Boc-protected amine, which is a common structural motif in synthetic chemistry. This Boc group offers protection during synthesis and can be easily removed under acidic conditions to reveal the reactive amine.

Reactive Site: The primary reactive site is the terminal amine, which couples with the target protein ligand through amide bond formation. Recommended reactions include standard peptide coupling methods, such as using EDC or HATU, to achieve efficient conjugation.

Recommended Target Protein Ligand: A suitable warhead for this molecule would be a small molecule inhibitor with a carboxylic acid functional group. This compatibility allows for effective amide bond formation with the terminal amine, facilitating the creation of a stable PROTAC. This approach is advantageous for targeting proteins implicated in various diseases, enabling precise modulation of protein levels for research applications.